BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 31500784)

  • 1. Does transanal total mesorectal excision of rectal cancer improve histopathology metrics and/or complication rates? A meta-analysis.
    Gachabayov M; Tulina I; Bergamaschi R; Tsarkov P
    Surg Oncol; 2019 Sep; 30():47-51. PubMed ID: 31500784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of open vs laparoscopic vs robotic vs transanal total mesorectal excision (TME) for rectal cancer: a network meta-analysis.
    Seow W; Dudi-Venkata NN; Bedrikovetski S; Kroon HM; Sammour T
    Tech Coloproctol; 2023 May; 27(5):345-360. PubMed ID: 36508067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of short-term clinical outcomes between transanal and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: A meta-analysis.
    Xu W; Xu Z; Cheng H; Ying J; Cheng F; Xu W; Cao J; Luo J
    Eur J Surg Oncol; 2016 Dec; 42(12):1841-1850. PubMed ID: 27697315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of short- and long-term outcomes between laparoscope-assisted transanal total mesorectal excision and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: a meta-analysis].
    Zhang X; Gao Y; Dai X; Zhang H; Cheng X; Li Q; Cai X; Shen T; Sun X; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Aug; 21(8):924-935. PubMed ID: 30136274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision.
    Ma B; Gao P; Song Y; Zhang C; Zhang C; Wang L; Liu H; Wang Z
    BMC Cancer; 2016 Jul; 16():380. PubMed ID: 27377924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of transanal total mesorectal excision and robotic total mesorectal excision for low rectal cancer after neoadjuvant chemoradiotherapy.
    Shin JK; Kim HC; Yun SH; Park YA; Cho YB; Huh JW; Lee WY
    Surg Endosc; 2021 Dec; 35(12):6998-7004. PubMed ID: 33523275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME).
    2017 European Society of Coloproctology (ESCP) collaborating group
    Colorectal Dis; 2018 Sep; 20 Suppl 6():33-46. PubMed ID: 30255642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of transanal total mesorectal excision for patients with middle and low rectal cancer: A systematic review and meta-analysis.
    Hu D; Jin P; Hu L; Liu W; Zhang W; Guo T; Yang X
    Medicine (Baltimore); 2018 Jul; 97(28):e11410. PubMed ID: 29995787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer: a systematic review with meta-analysis.
    Jiang HP; Li YS; Wang B; Wang C; Liu F; Shen ZL; Ye YJ; Wang S
    Surg Endosc; 2018 Jun; 32(6):2632-2642. PubMed ID: 29464401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.
    Roodbeen SX; Penna M; Mackenzie H; Kusters M; Slater A; Jones OM; Lindsey I; Guy RJ; Cunningham C; Hompes R
    Surg Endosc; 2019 Aug; 33(8):2459-2467. PubMed ID: 30350103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term outcomes of transanal versus laparoscopic total mesorectal excision for mid-to-low rectal cancer: a meta-analysis.
    Zhang X; Gao Y; Dai X; Zhang H; Shang Z; Cai X; Shen T; Cheng X; Yu K; Li Y
    Surg Endosc; 2019 Mar; 33(3):972-985. PubMed ID: 30374790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of trans-anal versus laparoscopic total mesorectal excision on the surgical and pathologic outcomes of patients with rectal cancer: meta-analysis of randomized controlled trials.
    Farooqi M; Hussain A; Ahmad A; Zaheer Z; Daniyal M; Tahir A; Fatima L; Maham R; Farooqui A; Khan A
    Langenbecks Arch Surg; 2023 Oct; 408(1):413. PubMed ID: 37861749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total mesorectal excision for low and middle rectal cancer: laparoscopic versus transanal approach-a meta-analysis.
    Aubert M; Mege D; Panis Y
    Surg Endosc; 2020 Sep; 34(9):3908-3919. PubMed ID: 31617090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic total mesorectal excision versus transanal total mesorectal excision for mid and low rectal cancer: A systematic review and meta-analysis.
    Yi Chi Z; Gang O; Xiao Li F; Ya L; Zhijun Z; Yong Gang D; Dan R; Xin L; Yang L; Peng Z; Yi L; Dong L; De Chun Z
    Medicine (Baltimore); 2024 Jan; 103(4):e36859. PubMed ID: 38277570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transanal Versus Laparoscopic Total Mesorectal Excision: A Comparative Prospective Clinical Trial from Two Centers.
    Zuhdy M; Elmore U; Shams N; Hegazy MAF; Roshdy S; Eldamshety O; Metwally IH; Rosati R
    J Laparoendosc Adv Surg Tech A; 2020 Jul; 30(7):769-776. PubMed ID: 32240035
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrating a tumour appropriate transanal or robotic assisted approach to total mesorectal excision in high-volume rectal cancer practice is safe and cost-effective.
    Fleming C; Fernandez B; Boissieras L; Cauvin T; Denost Q
    J Robot Surg; 2023 Oct; 17(5):1979-1987. PubMed ID: 37099264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of transanal total mesorectal excision for rectal cancer: comparison of short-term outcomes with laparoscopic and open surgeries.
    Perdawood SK; Thinggaard BS; Bjoern MX
    Surg Endosc; 2018 May; 32(5):2312-2321. PubMed ID: 29098433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review and meta-analysis of robotic-assisted transabdominal total mesorectal excision and transanal total mesorectal excision: which approach offers optimal short-term outcomes for mid-to-low rectal adenocarcinoma?
    Butterworth JW; Butterworth WA; Meyer J; Giacobino C; Buchs N; Ris F; Scarpinata R
    Tech Coloproctol; 2021 Nov; 25(11):1183-1198. PubMed ID: 34562160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer.
    Rasulov AO; Mamedli ZZ; Gordeyev SS; Kozlov NA; Dzhumabaev HE
    Tech Coloproctol; 2016 Apr; 20(4):227-34. PubMed ID: 26794213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transanal total mesorectal excision: pathological results of 186 patients with mid and low rectal cancer.
    de Lacy FB; van Laarhoven JJEM; Pena R; Arroyave MC; Bravo R; Cuatrecasas M; Lacy AM
    Surg Endosc; 2018 May; 32(5):2442-2447. PubMed ID: 29101570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.